14-105411482-C-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001195082.2(TEX22):āc.265C>Gā(p.Gln89Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000241 in 1,242,360 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_001195082.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TEX22 | NM_001195082.2 | c.265C>G | p.Gln89Glu | missense_variant | 3/4 | ENST00000451127.3 | NP_001182011.1 | |
TEX22 | XM_006720234.4 | c.265C>G | p.Gln89Glu | missense_variant | 3/4 | XP_006720297.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TEX22 | ENST00000451127.3 | c.265C>G | p.Gln89Glu | missense_variant | 3/4 | 2 | NM_001195082.2 | ENSP00000397002 | P1 | |
TEX22 | ENST00000548638.5 | c.150+11992C>G | intron_variant, NMD_transcript_variant | 5 | ENSP00000449736 |
Frequencies
GnomAD3 genomes AF: 0.0000132 AC: 2AN: 151464Hom.: 0 Cov.: 33
GnomAD4 exome AF: 9.17e-7 AC: 1AN: 1090896Hom.: 0 Cov.: 30 AF XY: 0.00 AC XY: 0AN XY: 518984
GnomAD4 genome AF: 0.0000132 AC: 2AN: 151464Hom.: 0 Cov.: 33 AF XY: 0.0000135 AC XY: 1AN XY: 73992
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 11, 2023 | The c.265C>G (p.Q89E) alteration is located in exon 3 (coding exon 2) of the TEX22 gene. This alteration results from a C to G substitution at nucleotide position 265, causing the glutamine (Q) at amino acid position 89 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at